Introduce targeted single-base substitutions in Escherichia coli without double-strand breaks using a programmable deaminase system.
Our service provides a complete workflow from guide design to delivery of confirmed edited clones for research applications.
Our service introduces specific point mutations in the E. coli genome using a programmable deaminase system without inducing double-strand breaks.
We computationally design multiple guide RNAs targeting your region of interest, evaluating on-target efficiency and off-target potential to select optimal candidates.
Plasmid vectors encoding Cas nickase–deaminase fusions and guide expression cassettes are assembled and fully sequence-verified before transformation.
Each project uses a specific deaminase enzyme (cytidine or adenine) to achieve the desired base transition within a defined editing window.
Base editing machinery is delivered on a single plasmid with antibiotic selection, enabling straightforward transformation and screening.
Individual colonies are picked, propagated, and verified by Sanger sequencing to support homogenous edited populations.
Each project concludes with a handoff package of verified biological materials and project documentation.
Project details are defined during the design phase to match your specific target and application needs.
| Parameter | Typical project scope |
|---|---|
| Editing Type | C→T or A→G base substitution; other substitutions on a case-by-case basis |
| Target Region Size | Scoped per project after consultation |
| Guide RNA Count | Scoped per project after consultation |
| Number of Clones | Delivery of up to 5 confirmed edited clones (customizable during design) |
| Strain Compatibility | Common E. coli lab strains (e.g., MG1655, BW25113); other strains scoped per project |
| Off-Target Analysis | In silico prediction included; targeted amplicon sequencing of top predicted sites optional |
| Quality Control | Sanger sequencing of target region for every delivered clone; chromatogram and alignment provided |
A streamlined five-step process from target design to clone delivery.
We analyze your target sequence, design multiple guide RNAs, and select optimal candidates based on in silico off-target evaluation and editing window placement.
Plasmid vectors encoding the Cas nickase-deaminase fusion and guide expression cassette are assembled using standard cloning or synthesis and confirmed by full-plasmid sequencing.
The validated editor plasmid is transformed into the specified E. coli host strain; transformants are selected on antibiotic-containing.
Individual colonies are isolated, cultured, and genomic DNA is extracted for PCR amplification of the target region.
Sanger sequencing is performed on each clone; editing efficiency is assessed, and confirmed edited clones are purified and archived.
Enabling precise point mutations for a range of research and engineering goals.
Introduce missense or nonsense mutations in coding sequences to study gene function without the risk of double-strand break-induced lethality.
Precisely alter enzyme active sites or regulatory regions to redirect metabolic flux and evaluate product yields.
Generate promoter or ribosome-binding site mutations to modulate gene expression levels predictably.
Common questions about our E. coli base editing service.
Editing efficiency depends on target sequence context and the protospacer adjacent motif (PAM) requirements of the Cas variant used. We evaluate multiple guide designs to identify the best-accessible site within your region of interest and will inform you if constraints limit editability.
The service currently supports C→T (cytosine deamination) and A→G (adenine deamination) conversions, each enabled by a specific deaminase enzyme. Transversions or other substitutions are not directly accessible but may be achieved by multiplex approaches on a custom basis.
In silico off-target prediction is performed for each guide RNA to identify potential mismatched sites. If needed, targeted amplicon sequencing of the top predicted off-target loci can be included to assess unintended edits within the project scope.
Each delivered clone is isolated from a single colony, and the edited region is confirmed by Sanger sequencing. A sequencing alignment file, chromatograms, and a summary of editing efficiency are provided. Additional QC such as off-target amplicon sequencing can be included as part of the project scope.
Get a customized quote for your E. coli Base Editing project. Our experts will respond within 24 hours.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.